PulseCath Overview
- Year Founded
-
2007
- Status
-
Private
- Employees
-
15
- Latest Deal Type
-
2ndary - Private
- Investors
-
2
PulseCath General Information
Description
Developer of a circulatory support technology designed to assist the life-sustaining pumping functions of the failing heart. The company's devices help to generate blood flow and can be inserted through the femoral artery, enabling cardiologists and cardiac surgeons to provide reliable life support to their patients.
Contact Information
Website
www.pulsecath.comCorporate Office
- De Corridor 5C
- 3621 ZA Breukelen
- Netherlands
Corporate Office
- De Corridor 5C
- 3621 ZA Breukelen
- Netherlands
PulseCath Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Secondary Transaction - Private | 01-Apr-2026 | Completed | Generating Revenue | |||
| 3. Later Stage VC | 17-Sep-2021 | Completed | Generating Revenue | |||
| 2. Debt - General | 10-Oct-2016 | $3.36M | $3.36M | Completed | Generating Revenue | |
| 1. Later Stage VC | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
PulseCath Comparisons
Industry
Financing
Details
PulseCath Competitors (1)
One of PulseCath’s competitors is Abiomed, a Corporate Backed or Acquired company based in Danvers, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Abiomed | Corporate Backed or Acquired | Danvers, MA |
PulseCath Patents
PulseCath Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026160965-A1 | Pump-valve assembly for use in a blood circulation system. | Pending | 24-Jan-2025 | ||
| WO-2025198464-A1 | Method of manufacturing a catheter | Pending | 18-Mar-2024 | ||
| EP-4766426-A1 | Blood pump system, and blood pump driver | Pending | 24-Aug-2023 | ||
| WO-2025042270-A1 | Blood pump system, and blood pump driver | Inactive | 24-Aug-2023 | ||
| EP-4729084-A1 | Blood guide valve and ventricular assist pump device comprising same | Pending | 16-Jun-2023 | A61M60/117 |
PulseCath Signals
PulseCath Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Huadong Medicine | Corporation | Minority | ||
| Oost NL | Venture Capital | Minority |
PulseCath FAQs
-
When was PulseCath founded?
PulseCath was founded in 2007.
-
Where is PulseCath headquartered?
PulseCath is headquartered in Breukelen, Netherlands.
-
What is the size of PulseCath?
PulseCath has 15 total employees.
-
What industry is PulseCath in?
PulseCath’s primary industry is Therapeutic Devices.
-
Is PulseCath a private or public company?
PulseCath is a Private company.
-
What is PulseCath’s current revenue?
The current revenue for PulseCath is .
-
How much funding has PulseCath raised over time?
PulseCath has raised $3.36M.
-
Who are PulseCath’s investors?
Huadong Medicine and Oost NL have invested in PulseCath.
-
Who are PulseCath’s competitors?
Abiomed is a competitor of PulseCath.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process